1. Suprised by the price and that it was an all cash deal. 2. Looking to reallocate cash from the MEDI Deal; I cannot find a similar biotech in terms of disease focus, market cap, etc. Any suggestions? 3. Both CHIR and MEDI are biotechs that make vaccines and have an infectious disease focus. Both were bought out for cash by European large pharma. Any significance to this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.